Why the study?
Does left atrial ablation improve freedom from tachyarrhythmias in patients with persistent atrial fibrillation?
Does left atrial ablation improve freedom from tachyarrhythmias in patients with persistent atrial fibrillation?
Shorter duration of persistent AF predicts successful left atrial ablation, while right atrial ablation offers incremental efficacy for refractory cases.
Answers are grounded in this paper and cite their sources.
Shorter persistent AF duration was associated with ablation success; leaves open whether earlier intervention improves outcomes.
BACKGROUND: We sought to characterize patients with persistent atrial fibrillation (AF) who were successfully treated by ablation targeting the left atrium (LA). METHODS AND RESULTS: Ninety-three patients (58±10 years, 79 male) undergoing ablation of persistent AF were studied. During the first procedure, ablation was performed in the LA and coronary sinus, consisting of pulmonary vein isolation, linear ablation, and electrogram-based ablation. During follow-up after the first procedure, 35 patients (38%) remained free from tachyarrhythmias, 27 patients (29%) had atrial tachycardia, and 31 patients (33%) had AF. Duration of persistent AF according to medical history and whether AF was terminated by ablation were associated with the outcome (P=0.005, P=0.004, respectively). In multivariate analysis, the duration of persistent AF was the only predictor of freedom from AF (sinus rhythm or atrial tachycardia) (odds ratio, 0.80 for a 1-year increase; 95% confidence interval, 0.67 to 0.95; P=0.01). Of 31 patients in whom AF recurred during follow-up, electrogram-based ablation was performed in the right atrium in 26 patients. Sixteen of those patients (62%) remained free from AF during follow-up. Overall, 82% of patients were free from any tachyarrhythmias at 2-year follow-up after a median of 2 procedures. CONCLUSIONS: Patients with shorter duration of persistent AF were more likely to be free from AF by LA ablation. Right atrial ablation may provide incremental efficacy in patients who are refractory to LA ablation.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: